"Disease Models, Animal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Descriptor ID |
D004195
|
| MeSH Number(s) |
C22.232 E05.598.500 E05.599.395.080
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Disease Models, Animal".
Below are MeSH descriptors whose meaning is more specific than "Disease Models, Animal".
This graph shows the total number of publications written about "Disease Models, Animal" by people in this website by year, and whether "Disease Models, Animal" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 1999 | 0 | 2 | 2 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 4 | 4 |
| 2002 | 1 | 3 | 4 |
| 2003 | 1 | 2 | 3 |
| 2004 | 0 | 4 | 4 |
| 2005 | 0 | 4 | 4 |
| 2006 | 1 | 3 | 4 |
| 2007 | 0 | 7 | 7 |
| 2008 | 0 | 6 | 6 |
| 2009 | 0 | 5 | 5 |
| 2010 | 0 | 7 | 7 |
| 2011 | 0 | 7 | 7 |
| 2012 | 2 | 2 | 4 |
| 2013 | 0 | 4 | 4 |
| 2014 | 1 | 7 | 8 |
| 2015 | 0 | 4 | 4 |
| 2016 | 0 | 6 | 6 |
| 2017 | 0 | 2 | 2 |
| 2018 | 0 | 5 | 5 |
| 2019 | 1 | 5 | 6 |
| 2020 | 0 | 9 | 9 |
| 2021 | 0 | 4 | 4 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 2 | 2 |
| 2024 | 2 | 5 | 7 |
| 2025 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Disease Models, Animal" by people in Profiles.
-
Identification of p38 MAPK inhibition as a neuroprotective strategy for combinatorial SMA therapy. EMBO Mol Med. 2025 Oct; 17(10):2762-2786.
-
E-Cigarette Smoke Exposure Elevates Renal MR Expression and Induces BP Elevation. Hypertension. 2025 Sep; 82(9):1492-1504.
-
Anti-Inflammatory Oxysterol, Oxy210, Inhibits Atherosclerosis in Hyperlipidemic Mice and Inflammatory Responses of Vascular Cells. Cells. 2024 Sep 30; 13(19).
-
Repurposing of the analgesic Neurotropin for MASLD/MASH treatment. Hepatol Commun. 2024 08 01; 8(8).
-
Epithelial Membrane Protein 2 (EMP2) Blockade Attenuates Pathological Neovascularization in Murine Oxygen-Induced Retinopathy. Invest Ophthalmol Vis Sci. 2024 Jul 01; 65(8):10.
-
Ambient Particulate Matter Induces In Vitro Toxicity to Intestinal Epithelial Cells without Exacerbating Acute Colitis Induced by Dextran Sodium Sulfate or 2,4,6-Trinitrobenzenesulfonic Acid. Int J Mol Sci. 2024 Jun 29; 25(13).
-
Targeting the long non-coding RNA MIAT for the treatment of fibroids in an animal model. Clin Sci (Lond). 2024 Jun 19; 138(12):699-709.
-
89Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors. Mol Cancer Ther. 2024 Jun 04; 23(6):890-903.
-
PPARa Agonism Enhances Immune Response to Radiotherapy While Dietary Oleic Acid Results in Counteraction. Clin Cancer Res. 2024 May 01; 30(9):1916-1933.
-
Effects of Empagliflozin on Vascular and Skeletal Mineralization in Hyperlipidemic Mice. Vascul Pharmacol. 2024 06; 155:107376.